Boston Scientific Overview
Boston Scientific Target Price
Analysts' 12-month price predictions for BSX.
Share Price
$72.03
Average Target Price
$80.31
11.5% upside
11.5% upside13 analysts in the last 4 months
High: $86 | Low: $73
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-25 | OppenheimerSteven Lichtman | $77 | 6.9% upside |  |
| 2024-04-25 | Evercore ISIVijay Kumar | $78 | 8.3% upside | |
| 2024-04-25 | RBC CapitalShagun Singh | $82 | 13.8% upside | |
| 2024-04-25 | Mizuho SecuritiesAnthony Petrone | $85 | 18% upside | |
| 2024-04-25 | Robert W. BairdDavid Rescott | $84 | 16.6% upside | |
| 2024-04-25 | Truist FinancialRichard Newitter | $86 | 19.4% upside | |
| 2024-04-25 | Wells FargoLawrence Biegelsen | $82 | 13.8% upside | |
| 2024-04-24 | Deutsche BankPito Chickering | $73 | 1.3% upside | |
| 2024-04-24 | BTIGMarie Thibault | $80 | 11.1% upside | |
| 2024-04-24 | Stifel NicolausRick Wise | $83 | 15.2% upside | |
| 2024-04-15 | BTIGMarie Thibault | $74 | 2.7% upside | |
| 2024-04-03 | Argus ResearchJohn Eade | $80 | 11.1% upside | |
| 2024-02-01 | Mizuho SecuritiesAnthony Petrone | $80 | 11.1% upside | |
| 2023-02-02 | J.P. Morgan | $55 |  23.6% downside | |
| 2023-02-02 | Needham | $53 | 26.4% downside | |
| 2023-01-06 | Morgan Stanley | $56 | 22.3% downside | |
| 2022-12-22 | Mizuho SecuritiesAnthony Petrone | $52 | 27.8% downside | |
| 2022-12-20 | Truist Financial | $54 | 25% downside | |
| 2022-12-08 | Raymond James | $54 | 25% downside | |
| 2022-07-28 | Raymond James | $48 | 33.4% downside | |
| 2022-07-28 | BTIG | $50 | 30.6% downside | |
| 2022-07-20 | Truist Financial | $45 | 37.5% downside | |
| 2022-06-29 | Canaccord Genuity | $43 | 40.3% downside | |
| 2022-06-24 | BTIG | $45 | 37.5% downside | |
| 2022-04-30 | Piper SandlerMatt O’Brien | $50 | 30.6% downside | |
| 2022-04-28 | Raymond James | $50 | 30.6% downside | |
| 2022-04-28 | Leerink Partners | $48 | 33.4% downside | |
| 2022-03-03 | Bank of America SecuritiesTravis Steed | $55 | 23.6% downside | |
| 2022-02-02 | BTIGMarie Thibault | $52 | 27.8% downside | |
| 2022-02-02 | Cowen & Co.Josh Jennings | $50 | 30.6% downside | |
| 2021-12-09 | MacquarieLuke McFarlane | $51 | 29.2% downside | |
| 2021-10-28 | UBSBrent Dilts | $118 | 63.8% upside | |
| 2021-10-28 | Canaccord GenuityWilliam Plovanic | $51 | 29.2% downside | |
| 2021-10-27 | Piper SandlerMatthew O'Brien | $51 | 29.2% downside | |
| 2021-09-23 | Credit SuisseMatt Miksic | $54 | 25% downside | |
| 2021-09-22 | JefferiesAnthony Petrone | $55 | 23.6% downside | |
| 2021-08-02 | Argus ResearchJohn Eade | $132 | 83.3% upside | |
| 2021-08-01 | Wells FargoLarry Biegelsen | $52.5 | 27.1% downside | |
| 2021-07-27 | Stifel NicolausRick Wise | $50 | 30.6% downside | |
| 2021-07-14 | Goldman SachsAmit Hazan | $50 | 30.6% downside | |
| 2021-04-29 | StephensChris Cooley | $52 | 27.8% downside | |
| 2021-04-28 | OppenheimerSteven Lichtman | $47 | 34.7% downside | |
| 2021-04-28 | CitigroupJoanne Wuensch | $51 | 29.2% downside | |